Strategies for individual phenotyping of linoleic and arachidonic acid metabolism using an oral glucose tolerance test.
Where this comes from
- Record sourced from PubMed, PMID 25786212.
- Also identified by DOI 10.1371/journal.pone.0119856 and PMC identifier 4364740.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
The ability to restore homeostasis upon environmental challenges has been proposed as a measure for health. Metabolic profiling of plasma samples during the challenge response phase should offer a profound view on the flexibility of a phenotype to cope with daily stressors. Current data modeling approaches, however, struggle to extract biological descriptors from time-resolved metabolite profiles that are able to discriminate between different phenotypes. Thus, for the case of oxylipin responses in plasma upon an oral glucose tolerance test we developed a modeling approach that incorporates a priori biological pathway knowledge. The degradation pathways of arachidonic and linoleic acids were modeled using a regression model based on a pseudo-steady-state approximated model, resulting in a parameter A that summarizes the relative enzymatic activity in these pathways. Analysis of the phenotypic parameters As suggests that different phenotypes can be discriminated according to preferred relative activity of the arachidonic and linoleic pathway. Correlation analysis shows that there is little or no competition between the arachidonic and linoleic acid pathways, although they share the same enzymes.
Medical subject headings
- Arachidonic Acid
- Glucose Tolerance Test
- Linoleic Acid
- Metabolic Networks and Pathways
- Models, Biological
- Oxylipins
- Phenotype